Browse Articles
Discover research articles across all indexed journals
Estrogen-Regulated Lateral Septal Kisspeptin Neurons Abundantly Project to GnRH Neurons and the Hypothalamic Supramammillary Nucleus
While hypothalamic kisspeptin (KP) neurons play well-established roles in the estrogen-dependent regulation of reproduction, little is known about extrahypothalamic KP-producing (KPLS) neurons of the lateral septum. As established previously,Kiss1expression in this region is low and regulated by estrogen receptor- and GABABreceptor-dependent mechanisms. Our present experiments onKiss1-Cre/ZsGreenknock-in mice revealed that transgene expression in the LS begins at Postnatal Day (P)33–36 in females and P40–45 in males and is stimulated by estrogen receptor signaling. Fluorescent cell numbers continue to increase in adulthood and are higher in females. Viral tracing uncovered that the bulk of KPLSfibers joins the medial forebrain bundle and terminates in the hypothalamic supramammillary nucleus. Smaller subsets innervate the medial amygdala or project to other limbic structures. One-quarter of gonadotropin-releasing hormone (GnRH)-immunoreactive perikarya in the preoptic area and their dendrites receive appositions from KPLSaxons. OVX adultKiss1-Cre/ZsGreenmice treated for 4 d with 17β-estradiol or vehicle were used for RNA sequencing studies of laser-microdissected KPLSneurons. The transcriptome included markers of GABAergic and neuropeptidergic (Penk,Cartpt,Vgf) cotransmission and 571 estrogen-regulated transcripts. Estrogen treatment upregulated the acetylcholine receptor transcriptChrm2and, in slice electrophysiology experiments, caused enhanced muscarinic inhibition of KPLSneurons. Finally, we provided immunohistochemical evidence for homologous neurons in the postmortem human brain, suggesting that KPLSneurons may contribute to evolutionarily conserved regulatory mechanisms. Future studies will need to investigate the putative roles of KPLSneurons in the estrogen-dependent control of GnRH neurons and/or various hypothalamic/limbic functions.
Long term outcomes of patients with chronic kidney disease after COVID-19 in an urban population in the Bronx
Abstract We investigated the long-term kidney and cardiovascular outcomes of patients with chronic kidney disease (CKD) after COVID-19. Our retrospective cohort consisted of 834 CKD patients with COVID-19 and 6,167 CKD patients without COVID-19 between 3/11/2020 to 7/1/2023. Multivariate competing risk regression models were used to estimate risk (as adjusted hazard ratios (aHR) with 95% confidence intervals (CI)) of CKD progression to a more advanced stage (Stage 4 or 5) and major adverse kidney events (MAKE), and risk of major adverse cardiovascular events (MACE) at 6-, 12-, and 24-month follow up. Hospitalized COVID-19 patients at 12 and 24 months (aHR 1.62 95% CI[1.24,2.13] and 1.76 [1.30, 2.40], respectively), but not non-hospitalized COVID-19 patients, were at higher risk of CKD progression compared to those without COVID-19. Both hospitalized and non-hospitalized COVID-19 patients were at higher risk of MAKE at 6-, 12- and 24-months compared to those without COVID-19. Hospitalized COVID-19 patients at 6-, 12- and 24-months (aHR 1.73 [1.21, 2.50], 1.77 [1.34, 2.33], and 1.31 [1.05, 1.64], respectively), but not non-hospitalized COVID-19 patients, were at higher risk of MACE compared to those without COVID-19. COVID-19 increases the risk of long-term CKD progression and cardiovascular events in patients with CKD. These findings highlight the need for close follow up care and therapies that slow CKD progression in this high-risk subgroup.
Suture versus stapler in distal pancreatectomy and its impact on postoperative pancreatic fistula
Exercise reduces the risk of falls in women with polypharmacy: secondary analysis of a randomized controlled trial
Abstract Polypharmacy has previously been found to increase and exercise interventions to reduce the risk of falls and fall-related injuries. In this study, women who had four or more regular medications benefitted the most from the exercise intervention and had the lowest fall risk compared to the reference group. Fall injuries among older people cause significant health problems with high societal costs. Previously, some exercise interventions have been found to reduce the number of falls and related injuries. We studied how different levels of medication use affect the outcome of an exercise intervention in terms of preventing falls. This exercise RCT involved 914 women born in 1932–1945 and randomly assigned to the intervention (n = 457) and control (n = 457) groups. Both groups participated in functional tests three times during the study. Baseline self-reported prescription drug use was trichotomized: 0–1, 2–3, and ≥ 4 drugs/day (i.e. polypharmacy group). We used Poisson regression for follow-up fall risk and Kaplan-Meier survival analysis for fractures. During follow-up, 1380 falls were reported, 739 (53.6%) resulting in an injury and pain and 63 (4.6%) in a fracture. Women with polypharmacy in the intervention group had the lowest fall risk (IRR 0.713, 95% CI 0.586–0.866, p = 0.001) compared to the reference group that used 0–1 medications and did not receive the intervention. Overall, the number of medications associated with the fall incidence was only seen in the intervention group. However, the number of medications was not associated with fractures in either of the groups. Weaker functional test results were associated with polypharmacy in the control group. The most prominent decrease in fall risk with exercise intervention was seen among women with polypharmacy. Targeting these women might enhance fall prevention efficacy among the aging population. Trial Registration: The study has been registered in ClinicalTrials.gov. Trial registration number NCT02665169. Register date 27/01/2016.
Publisher Correction: Development of novel reduced graphene oxide/metalloporphyrin nanocomposite with photocatalytic and antimicrobial activity for potential wastewater treatment and medical applications
Early application value of flexible laryngoscope swallowing function assessment in patients after partial laryngectomy
Residual force depression is affected by muscle length
Sample entropy of oxygen saturation in preterm infants
Copper Chelate Targeting Externalized Phosphatidylserine Inhibits PD-L1 Expression and Enhances Cancer Immunotherapy
Efficacy and safety of esketamine for emergency endotracheal intubation in ICU patients: a double-blind, randomized controlled clinical trial
Modelling the effects of elevated methylglyoxal levels on vascular and metabolic complications
Multi-omics analysis reveals the panoramic picture of TOP2A in pan-cancer
Residual useful life prediction of lithium-ion battery based on accuracy SoH estimation
Self-reactive impedance surfaces for enhanced quasi-line wave propagation in the terahertz spectrum
Collision Timing and Provenance Shifts from the Late Oligocene to Middle Miocene in the Southeasternmost Zagros Orogen
Thermal hydrolysis of poultry byproducts for the production of microbial media
Interactive effects of irrigation and fertilization on the growth and physiological characteristics of greenhouse tomatoes, Solanum lycopersicum L.
COVID-19 affected elite track-and-field athletes’ Olympic preparation before Tokyo 2020 compared to Rio 2016
Abstract The COVID-19 pandemic has had a significant impact on elite sport by postponing the Olympic Games Tokyo 2020 four months before the original start. This impacted athletes’ macro-cycle periodization, psychological stressors and resources. We analyse whether track-and-field athletes were able to maintain their performance levels successfully across the last two Olympic cycles, controlling for age, gender and doping prevalence. For this, worldwide competition results (excluding multi-events & relays) of at least national level since London 2012 and up to Tokyo 2020 were retrieved. Individual performance curves were analysed using hierarchical multilevel modelling. Individual baselines (random intercept) and developments (random slope) were analysed. 2,383 athletes (52% male) recorded 15,766 outcomes since London 2012. The final conditional growth model (ICC = 48%) shows that performances increased in the wake of Olympic games, dropped significantly in 2020 and recovered beyond previous form in 2021. There was no significant difference between men’s and women’s developments. Age was a significant predictor (b = 0.17, SE = 0.02), but doping violations was not (b = 0.01, SE = 0.03). These results showcase performance trends in international athletics and their variability, present an overall successful periodization to achieve peak performance at Tokyo 2020, and discuss predictions for track and field at Paris 2024.